Concomitant polymorphic forms of 3‐cyclopropyl‐5‐(2‐hydrazinylpyridin‐3‐yl)‐1,2,4‐oxadiazole

The dipharmacophore compound 3‐cyclopropyl‐5‐(2‐hydrazinylpyridin‐3‐yl)‐1,2,4‐oxadiazole, C10H11N5O, was studied on the assumption of its potential biological activity. Two concomitant polymorphs were obtained on crystallization from isopropanol solution and these were thoroughly studied. Identical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta crystallographica. Section C, Crystal structure communications Crystal structure communications, 2020-08, Vol.76 (8), p.836-844
Hauptverfasser:	Shishkina, Svitlana V., Konovalova, Irina S., Karpina, Veronika R., Kovalenko, Svitlana S., Kovalenko, Sergiy M., Bunyatyan, Natalya D.
Format:	Artikel
Sprache:	eng
Schlagworte:	1,2,4‐oxadiazole Biological activity concomitant polymorphs Crystal structure Crystallization cyclopropyl Dimers dipharmacophore Hydrogen bonds Mathematical analysis Molecular structure Organic compounds Oxadiazoles pairwise interaction energies periodic calculations pyridine Stacking
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!